Cite
HARVARD Citation
Redondo, A. et al. (2019). Bendamustine as part of conditioning of autologous stem cell transplantation in patients with aggressive lymphoma: a phase 2 study from the GELTAMO group. British journal of haematology. pp. 797-807. [Online].